American Association for Cancer Research
Browse
00085472can093258-sup-sfig_4.pdf (48.88 kB)

Supplementary Figure 4 from Arrest Defective 1 Autoacetylation Is a Critical Step in Its Ability to Stimulate Cancer Cell Proliferation

Download (48.88 kB)
journal contribution
posted on 2023-03-30, 19:24 authored by Ji Hae Seo, Jong-Ho Cha, Ji-Hyeon Park, Chul-Ho Jeong, Zee-Yong Park, Hye-Suk Lee, Seung Hyun Oh, Ju-Hee Kang, Se Won Suh, Kyoung Hoon Kim, Jun Yong Ha, Sang Hee Han, Se-Hee Kim, Ji-Won Lee, Jeong Ae Park, Joo-Won Jeong, Kong-Joo Lee, Goo Taeg Oh, Mi-Ni Lee, Sung Won Kwon, Seung-Ki Lee, Kwang-Hoon Chun, Su-Jae Lee, Kyu-Won Kim
Supplementary Figure 4 from Arrest Defective 1 Autoacetylation Is a Critical Step in Its Ability to Stimulate Cancer Cell Proliferation

History

ARTICLE ABSTRACT

The N-acetyltransferase arrest defective 1 (ARD1) is an important regulator of cell growth and differentiation that has emerged recently as a critical molecule in cancer progression. However, the regulation of the enzymatic and biological activities of human ARD1 (hARD1) in cancer is presently poorly understood. Here, we report that hARD1 undergoes autoacetylation and that this modification is essential for its functional activation. Using liquid chromatography-tandem mass spectrometry and site-directed mutational analyses, we identified K136 residue as an autoacetylation target site. K136R mutation abolished the ability of hARD1 to promote cancer cell growth in vitro and tumor xenograft growth in vivo. Mechanistic investigations revealed that hARD1 autoacetylation stimulated cyclin D1 expression through activation of the transcription factors β-catenin and activator protein-1. Our results show that hARD1 autoacetylation is critical for its activation and its ability to stimulate cancer cell proliferation and tumorigenesis. Cancer Res; 70(11); 4422–32. ©2010 AACR.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC